Applications are now open for the 2026 Eppendorf & Science Prize for Neurobiology, marking the award’s 25th anniversary and recognizing exceptional early-career researchers in the field.
These late-stage therapies span obesity, diabetes, hypertension, and allergy care, offering new mechanisms and delivery formats that could reshape patient treatment.
By explicitly specifying treatment effects and intercurrent events, estimands help sponsors, clinicians, and regulators work from a shared understanding.
After decades of slow progress, advances in molecular profiling and organoid technology are creating new pathways for non-invasive diagnosis and targeted treatment of endometriosis.
Direct evidence of cardiomyocyte division in living human tissue reframes long-held assumptions about cardiac irreversibility, while underscoring how far therapies still have to go.